Atlas Venture has announced the launch of a new biotech startup Monday called Korro Bio, based on a technology that could be an improvement on current approaches to gene-editing which grew out of the study of the nervous systems of squid.
One of the new company’s co-founders is Josh Rosenthal, a researcher at the Marine Biological Laboratory in Woods Hole, who last year pitched an idea to partners at Cambridge-based Atlas to create drugs based on editing RNA — the genetic instructions that carry…
